Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of "Hold" by Brokerages

Key Points

• Teladoc Health, Inc. has received an average rating of "Hold" from 19 research firms, with 12 rating it as a hold and 7 providing a buy recommendation, reflecting cautious optimism about its future.
• Following a recent earnings report, Teladoc Health showcased a slight revenue increase of $631.90 million, surpassing analyst expectations, but also noted a decrease in earnings year-over-year.
• Insider transactions revealed significant selling activity, with key insiders reducing their stakes in the company, indicating potential concerns or strategic repositioning among current leadership.

Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) have been given an average recommendation of "Hold" by the nineteen analysts that are presently covering the company, Marketbeat.com reports. Twelve investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $9.7639.

Several analysts recently weighed in on TDOC shares. Truist Financial lowered their price objective on Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a report on Tuesday, May 27th. Evercore ISI lifted their target price on Teladoc Health from $7.00 to $8.00 and gave the company an "in-line" rating in a research note on Wednesday, July 9th. Mizuho began coverage on Teladoc Health in a research report on Friday, July 25th. They set a "neutral" rating and a $10.00 price objective for the company. Bank of America cut their target price on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 28th. Finally, Citigroup lowered their price target on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research report on Friday, April 25th.

Teladoc Health Price Performance

Shares of TDOC traded up $0.06 during trading hours on Friday, reaching $7.55. 1,297,780 shares of the company traded hands, compared to its average volume of 6,971,902. The stock has a market capitalization of $1.33 billion, a PE ratio of -6.36 and a beta of 1.76. Teladoc Health has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. The stock has a fifty day simple moving average of $7.72 and a 200 day simple moving average of $8.28.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.08. The firm had revenue of $631.90 million during the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%. The firm's quarterly revenue was down 1.6% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.38) EPS. As a group, research analysts predict that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Activity

In other news, insider Fernando M. Rodrigues sold 4,174 shares of the firm's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total transaction of $28,842.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Adam C. Vandervoort sold 5,808 shares of the business's stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $39,842.88. Following the sale, the insider owned 69,773 shares in the company, valued at approximately $478,642.78. The trade was a 7.68% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 18,656 shares of company stock worth $128,189. Corporate insiders own 0.58% of the company's stock.

Hedge Funds Weigh In On Teladoc Health

Several hedge funds have recently bought and sold shares of TDOC. Golden State Wealth Management LLC raised its position in shares of Teladoc Health by 102.6% in the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after purchasing an additional 1,690 shares during the period. National Bank of Canada FI grew its holdings in Teladoc Health by 79.4% in the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after buying an additional 1,581 shares during the last quarter. SVB Wealth LLC acquired a new position in shares of Teladoc Health during the first quarter worth approximately $37,000. Sterling Capital Management LLC boosted its position in shares of Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after acquiring an additional 4,101 shares during the period. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new position in Teladoc Health during the first quarter worth $50,000. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.